GlucoTrack, Inc. (GCTK) vs Propanc Biopharma, Inc. (PPCB)
A side-by-side comparison of GlucoTrack, Inc. and Propanc Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GCTK
GlucoTrack, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
PPCB
Propanc Biopharma, Inc.
$0.52HealthcareDelayed quote: Oct 6, 2026, 12:12 PM EDT
Total return — GCTK vs PPCB
growth of $100 · dividends reinvested · last 10yGCTK -100.0% (-66.9%/yr)PPCB -100.0% (-89.4%/yr)GCTK compounded faster over this window
Log scale — wide-divergence pair
GCTK PPCB
GCTK vs PPCB: by the numbers
- •PPCB is the larger company ($1M vs $869976 market cap).
Metrics side by side
Valuation
| Metric | GCTK | PPCB |
|---|---|---|
| P/B ratio | N/A | 0.13 |
Profitability
| Metric | GCTK | PPCB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -200.63% |
| ROIC | N/A | -183.49% |
Growth (annualized)
| Metric | GCTK | PPCB |
|---|---|---|
| Total return CAGR (5Y) | -92.60% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.